P394 Rate of and response to dose escalation in patients treated with adalimumab for moderately to severely active ulcerative colitis: subanalysis of ULTRA 2 | Zendy

AI Assistant Blog Pricing

P394 Rate of and response to dose escalation in patients treated with adalimumab for moderately to severely active ulcerative colitis: subanalysis of ULTRA 2

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.